NCT02250430

A Phase 1 Study Assessing Local Cutaneous Effects of SB204

A Phase 1, Single-Center, Split-Face Study Assessing Local Cutaneous Effects After Application of SB204 2% and SB204 4% in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 8 (actual)
• Sponsor: Novan, Inc. · Industry
• Sex: All
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

In this study, color (erythema) and pH will be measured on 3 consecutive days after application of 2 doses of SB204 to the cheeks of healthy volunteers.

Detailed description

This study is to evaluate local cutaneous effects, including intensity and duration of erythema and changes in pH following 5 applications (twice daily for two days and once daily on the third day) of SB204 2% and SB204 4% twice daily to the face for 3 days.

Conditions

• Acne Vulgaris

Interventions

Type	Name	Description
DRUG	SB204	Applied topically twice a day on days 1, 2 and 3 to left and right cheeks

Timeline

• Start date: 2014-09-01
• Primary completion: 2014-09-01
• Completion: 2014-09-01
• First posted: 2014-09-26
• Last updated: 2018-11-19

Locations

1 site across 1 country: United States